subscribeSubscribe
Farma Mondo Group & Helsinn sign exclusive partnership to commercialize AKYNZEO

Farma Mondo Group & Helsinn sign exclusive partnership to commercialize AKYNZEO
GLOBENEWSWIRE
28 Nov 2022
Share Share
Helsinn Group and Italfarmaco announces oral presentation of NEPA data

Helsinn Group and Italfarmaco announces oral presentation of NEPA data
PRESS RELEASE
18 Sep 2020
Share Share
Helsinn announces launch of oral formulation of Akynzeo® in China

Helsinn announces launch of oral formulation of Akynzeo® in China
GLOBENEWSWIRE
08 Jun 2020
Share Share
Glenmark launches Helsinn`s Akynzeo in India

Glenmark launches Helsinn`s Akynzeo in India
BIOSPECTRUM
11 Jul 2018
Share Share
Glenmark expands its oncology franchise in India with launch of Akynzeo

Glenmark expands its oncology franchise in India with launch of Akynzeo
ECONOMIC TIMES
11 Jul 2018
Share Share
Glenmark launches FDC drug Akynzeo for chemotherapy-induced nausea and vomiting

Glenmark launches FDC drug Akynzeo for chemotherapy-induced nausea and vomiting
PHARMABIZ
10 Jul 2018
Share Share
Glenmark gets license to market Akynzeo in India

Glenmark gets license to market Akynzeo in India
THEPHARMALETTER
04 Apr 2018
Share Share
Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise

Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise
PR NEWS WIRE
18 Mar 2016
Share Share
Six new therapies approved for NHS Scotland

Six new therapies approved for NHS Scotland
Selina McKee PHARMATIMES
12 Jan 2016
Share Share
Helsinn Group and Eisai Inc. Announce Inclusion of AKYNZEO in ASCO

Helsinn Group and Eisai Inc. Announce Inclusion of AKYNZEO in ASCO
PR NEWS WIRE
13 Nov 2015
Share Share